MetroGel V, the preferred choice for the treatment of Bacterial Vaginosis (BV) by South African gynaecologists1, has had a facelift. The same trusted product now comes in beautifully designed floral packaging, adding visual appeal to the product and aligning to its therapeutic goal of re-establishing vaginal flora2.

The new packaging aims to empower women to take control of their vaginal health. The floral image not only makes the packaging more feminine and appealing but also imbues the importance of a vaginal flora in maintaining vaginal health. 

The campaign focuses on the importance of Lactobacilli – the super hero of a healthy vaginal environment3. 

Lactobacilli is a type of bacteria naturally found in the vagina. It helps maintain a healthy environment and prevent infections4. Lactobacilli produce lactic acid and hydrogen peroxide. Lactic acid acidifies the vagina to help protect against a broad range of infections5 and hydrogen peroxide and antimicrobial compounds prevent overgrowth of pathogenic bacteria3 6. 

A lack of Lactobacilli may lead to overgrowth of pathogenic organisms and bacterial vaginosis4, 7. 

MetroGel V contains metronidazole gel 0.75 % and is a recommended regimen for the treatment of BV by the Centers for Disease Control and Prevention (CDC)8. Intravaginal metronidazole helps to restore vaginal Lactobacilli colonisation3. Clinical studies showed a 61 % increase in the growth of vaginal Lactobacilli one week after treatment, in comparison to treatment with clindamycin which only showed 11 % growth of Lactobacilli3. 

Use of MetroGel V has also been shown to have significantly fewer gastro-intestinal adverse events than oral metronidazole9 and is available without a prescription10. 

MetroGel V is a water-based gel that stays in the vagina and is convenient and easy to use. It should be used once daily at bedtime for 5 days10. 

iNova Pharmaceuticals is committed to helping patients with Bacterial Vaginosis (BV) to improve their day to day lives. Go to www.myvaginalgel.co.za for more information.

DISCLAIMER: This editorial has been commissioned and brought to you by iNova Pharmaceuticals. Content in this editorial is for general information only and is not intended to provide medical or other professional advice. 

Scheduling status: S2 Proprietary name (and dosage form): MetroGel V Vaginal Gel. Composition: Metronidazole 37.5 mg/5 g. Preservatives: Methyl hydroxybenzoate 0.08%, Propyl hydroxybenzoate 0.02%. Pharmacological classification: A 20.2.6 Antimicrobial: medicines against protozoa. Indications: MetroGel V is indicated for the treatment of bacterial vaginosis. Registration number: 33/20.2.6/0243 Name and business address of applicant: iNova Pharmaceuticals (Pty) Ltd, Co. Reg. No. 1952/001640/07, 15E Riley Road, Bedfordview. Tel. No. 011 087 0000. www.inovapharma.co.za. For full prescribing information, refer to the package insert as approved by SAHPRA (South African Health Products Regulatory Authority.  IN3476/19